Stopping scans for stable pancreatic cysts
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks at whether people aged 70 and older with a certain type of stable pancreatic cyst (called BD-IPMN) can safely stop having follow-up scans. If you have had these cysts for at least 5 years without any worrying changes, this trial may help you avoid unnecessary testing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 70 years of age or older.
- You have a type of pancreatic cyst called BD-IPMN that has not changed for at least 5 years.
- The main pancreatic duct is not widened (5 millimeters or less).
- The cyst is 30 millimeters or smaller.
- You have no signs of concern (like worrisome features or high-risk signs) now or when the cyst was first found.
- You have no personal or family history of pancreatic cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how medical images and lab samples can predict which pancreatic cysts or tumors are more likely to be dangerous. If you are being evaluated for a pancreatic problem and haven’t started pancreas treatment, your scans and samples may help researchers improve risk prediction.
This study collects information from people who have an IPMN cyst in the pancreas to help predict who may be at higher risk of pancreatic cancer. It may help your care team estimate risk and plan follow-up more effectively.
This registry study collects information from adults who have a pancreatic cyst (a fluid-filled sac in the pancreas). It may help doctors understand these cysts and how they change over time, which can improve future care.
This trial tests whether regular MRI scans can help catch pancreatic cancer early in people who have intermediate- or high-risk IPMN (a type of pancreatic cyst). It aims to find cancer sooner to improve treatment options.
This study tests a special MRI scan and blood tests to see if they can detect early pancreatic cancer in people with high-risk pancreatic cysts called IPMNs. It may help identify cancer earlier, when treatment is more likely to work.
This study compares different ways to monitor pancreatic cysts and also measures blood or other test markers to see which approach is more helpful. It may help patients by finding the safest, most effective way to track certain cysts that could otherwise be hard to manage.
Hear when a new IPMN trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.